Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer

Clinical trial NCT03425656 · COMPLETED

Trial details

NCT number: NCT03425656
Sponsor: AryoGen Pharmed Co.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Malignant Neoplasm of Breast

Start date: 2016-07-09
Primary completion: 2018-03-06
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.